Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 1.710
+0.108 (6.74%)
Nov 2, 2026, 4:30 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 482.13 million as of November 2, 2026. It is the 30,614th most valuable company in the world and the 408th biggest in Sweden. Its market cap has decreased by 44.75% in one year.
Market Cap
482.13M
Enterprise Value
260.17M
Revenue
317.31M
Global Rank
Country Rank
#408 Sweden
PE Ratio
2.56
ChartMarket Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 482.13M, an increase of 299.93%. That is a compound annual growth rate of 12.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 482.13M | -53.66% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |
| FluoGuide | 498.65M |
| Isofol Medical AB | 383.95M |
| Sprint Bioscience AB | 379.86M |
| Corline Biomedical AB | 371.09M |
| BioInvent International AB | 357.32M |
| Mendus AB | 352.63M |